Drug Shortage Report for BIPAZEN
| Report ID | 232584 |
| Drug Identification Number | 02513579 |
| Brand name | BIPAZEN |
| Common or Proper name | Desmopressin Acetate Injection |
| Company Name | KVR PHARMACEUTICALS INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | DESMOPRESSIN ACETATE |
| Strength(s) | 4MCG |
| Dosage form(s) | SOLUTION |
| Route of administration | SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR |
| Packaging size | Cartons of 10 ampoules |
| ATC code | H01BA |
| ATC description | POSTERIOR PITUITARY LOBE HORMONES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2024-07-19 |
| Actual start date | |
| Estimated end date | 2024-12-30 |
| Actual end date | 2024-12-30 |
| Shortage status | Resolved |
| Updated date | 2024-12-31 |
| Company comments | Bipazen is back in stock. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 21 PARR BLVD, UNIT 12 CALEDON, ONTARIO CANADA L7E 4G3 |
| Company contact information | 1 877 302 2561 ext 101 [email protected] |
Version History
Click on "Compare" below to view the full report history and compare to other versions.